Personalized 6-Month Diet and Exercise Program Using Wearable Devices and AI Support for Adults With Obesity

What this Trial Is About

Researchers are studying overweight and obese adults to evaluate the effectiveness of a 6-month personalized diet and exercise program aimed at promoting weight loss. This study focuses on different obesity levels and examines the role of galectin-1, a protein linked to inflammation and fat tissue, in relation to weight loss and metabolic changes. The research compares standard care with an intervention using wearable devices and artificial intelligence AI apps to support lifestyle changes. Participants are divided into two groups one follows a standard diet and exercise program based on Mediterranean diet principles and physical activity guidelines, while the other group uses wearable devices and AI apps alongside the same program. The devices track steps, heart rate, and calories burned, and participants log their food intake using a smartphone app. The program includes outpatient visits at weeks 0, 12, and 24, with phone consultations at weeks 2, 4, and 8 to provide coaching and guidance. Weight loss medications are not allowed during the study. During the study, researchers measure participants weight, height, blood pressure, waist circumference, body composition, and blood samples to assess glucose, cholesterol, triglycerides, insulin, and galectin-1 levels. Measurements are taken at the start and at week 24. Participants receive diet and exercise education, and case managers offer coaching through a health management platform. The main outcome measured is weight change after 24 weeks, along with secondary outcomes like waist size, blood pressure, and cholesterol levels.

A Wearable Device and AI-Supported Diet and Exercise Intervention